ARTICLE | Clinical News
OBE001: Phase II started
December 15, 2014 8:00 AM UTC
ObsEva began the double-blind, placebo-controlled, European Phase II IMPLANT trial to evaluate 3 single doses of oral OBE001 in about 240 women ages 18-36 undergoing embryo transfer after in vitro fer...